Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
AG-126 for ERK Signaling Assays and Neurobiology
2026-08-20
AG-126 provides a practical way to test whether ERK1/2 activity contributes to stimulus-responsive signaling, cytokine release, or neuronal phenotypes. This workflow connects established inflammatory-model evidence with a carefully bounded neurobiology application inspired by Neuroligin 1 and D2-MSN research.
-
Dimethyloxalylglycine (DMOG) Protocol Guide
2026-08-20
Dimethyloxalylglycine (DMOG), SKU A4506, provides a practical pharmacologic approach for hypoxia-inducible factor stabilization under normoxic cell-culture conditions and for selected inflammation models. It is a research reagent only; the available dossier does not establish diagnostic, therapeutic, or clinical use, and no directly matched paper evidence is available for this product entry.
-
Brefeldin A Workflows for ER Stress and Cancer
2026-08-19
Brefeldin A converts disrupted ER-to-Golgi trafficking into a controllable experimental stress, making BFA useful for secretion studies, ER quality-control assays, and cancer phenotyping. This guide combines practical dosing, time-course design, apoptosis and migration readouts, and troubleshooting for more interpretable results.
-
HyperFluor 488 Goat Anti-Mouse IgG Guide
2026-08-19
HyperFluor 488 Goat Anti-Mouse IgG is a fluorescently labeled secondary antibody for detecting mouse IgG in immunofluorescence, flow cytometry, and western blot workflows. Its H+L specificity, affinity purification, and defined storage formulation support sensitive research detection when host species, controls, and fluorescence handling are properly validated.
-
Preserving Protein Fidelity in Translational AD Research
2026-08-18
Translational atopic dermatitis research increasingly depends on connecting phenotype with intact, interpretable molecular evidence. This thought-leadership article explains how protease control can strengthen protein extraction, phosphorylation analysis, Western blotting, and immunoprecipitation workflows while clarifying where an EDTA-free cocktail fits—and where it does not—in the path from preclinical evidence to clinical confidence.
-
HLY78: Wnt/β-Catenin Pathway Modulator
2026-08-18
HLY78 provides ligand-dependent control of Wnt/β-catenin signaling for developmental, stem-cell, and fibrosis-model experiments. Its Axin-directed mechanism supports pathway-rescue designs that distinguish physiological potentiation from constitutive pathway activation.
-
3-Deazaadenosine Hydrochloride in m6A Assays
2026-08-17
3-Deazaadenosine hydrochloride is an S-adenosylhomocysteine hydrolase inhibitor for probing methylation-dependent biology. This guide translates the IGF2BP1–TUBB4B liver-fibrosis study into rigorous assay design, controls, and interpretation strategies.
-
Tunable Human Intestinal Organoids: Study Insights
2026-08-17
Yang and colleagues developed a human small intestinal organoid system that maintains strong proliferation while expanding cellular diversity under a single culture condition. The study shows that coordinated pathway modulation can reversibly or directionally shift lineage output, offering a more scalable framework for intestinal development, disease modeling, and screening.
-
Berberrubine chloride: Applied Research Workflows
2026-08-16
Berberrubine chloride supports mechanism-led workflows spanning colorectal cancer, NSCLC chemosensitivity, and hyperuricemia research. This guide translates its DMSO formulation, concentration ranges, target selectivity, and troubleshooting considerations into practical assay designs.
-
(R,S)-Anatabine: Aβ Assay Architecture
2026-08-15
Explore how (R,S)-Anatabine can be evaluated through an integrated assay architecture linking APP processing, BACE-1 regulation, inflammation, and soluble Aβ peptide reduction. This guide adds a tissue-context perspective from NLRP10 biology while defining practical boundaries for neurodegeneration research.
-
2X Taq PCR Master Mix for Splicing Assays
2026-08-14
Use 2X Taq PCR Master Mix to simplify endpoint PCR for genotyping, isoform analysis, and TA cloning. Its built-in loading dye reduces transfer steps, while Taq-generated adenine overhangs support efficient downstream cloning workflows.
-
Firefly Luciferase mRNA: Reliable Assay Workflows
2026-08-14
Learn how EZ Cap™ Firefly Luciferase mRNA (5-moUTP), SKU R1013, can support more interpretable cell viability, proliferation, cytotoxicity, and mRNA translation studies. This scenario-based guide covers reporter biology, delivery compatibility, RNA handling, data interpretation, and practical product selection.
-
Auranofin in Redox and Mechanical-Stress Assays
2026-08-13
Auranofin is a thioredoxin reductase inhibitor for connecting redox imbalance with apoptosis, radiosensitization, and stress-induced autophagy. This workflow shows how to pair dose-response assays with controlled mechanical compression while separating established product benchmarks from practical assay recommendations.
-
Biotin-16-UTP: Practical RNA Labeling Guide
2026-08-13
Biotin-16-UTP is a biotin-labeled uridine triphosphate for incorporating an affinity handle into RNA during in vitro transcription. It supports RNA detection and purification, RNA-protein interaction studies, and localization workflows, but should be used only for research and with assay-specific optimization rather than as a diagnostic or therapeutic reagent.
-
Small Micellar Paclitaxel for Brain Gliomas
2026-08-12
A 2025 Pharmaceutics study developed Solutol HS-15-based paclitaxel micelles with a mean particle size of 13.45 nm and high drug encapsulation. In a C6 in situ glioma mouse model, the formulation increased brain drug exposure, suppressed tumor-associated bioluminescence, and reduced the toxicity observed with conventional paclitaxel treatment.